Oligonucleotide therapeutics, including small interfering RNAs (siRNAs), are a new class of medicine that enables the modulation of expression of disease-causing genes 1,2,3,4,5. Six siRNAs have been ...
The alternative text for this image may have been generated using AI. Fig. 4: Ribosomal synthesis of N-terminal functionalized peptides with backbone-extended monomers. The alternative text for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results